C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2011
11/30/2011	EP2389374A1 Substituted pyrazinone amides
11/30/2011	EP2389373A1 Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
11/30/2011	EP2389372A1 Compositions and methods for inhibition of the jak pathway
11/30/2011	EP2389366A1 Benzodiazepin-2-on derivatives
11/30/2011	EP2324010B1 Insecticidal phenyl- or pyridyl-piperidine compounds
11/30/2011	EP2310383B1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/30/2011	EP2276756B1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
11/30/2011	EP2231629B1 Modulators for amyloid beta
11/30/2011	EP2062886B1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
11/30/2011	EP2041069B1 Benzyl amines, a process for their production and their use as anti-inflammatory agents
11/30/2011	EP2010289B1 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
11/30/2011	EP1947098B1 Cyclic amine compounds and pest control agent
11/30/2011	EP1899324B1 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
11/30/2011	EP1633735B1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/30/2011	EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists
11/30/2011	EP1551810B1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
11/30/2011	CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists
11/30/2011	CN102264728A 用于调节ire1、src和abl活性的方法和组合物 The method used to adjust ire1, src and abl activity and composition
11/30/2011	CN102264725A 蛋白激酶抑制剂 Protein kinase inhibitors
11/30/2011	CN102264724A 制备艾美拉唑的方法 Preparation methods esomeprazole
11/30/2011	CN102264723A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier
11/30/2011	CN102264722A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮酰胺 As P2X <sub> Dihydropyridones amide 7 </ sub> modifier
11/30/2011	CN102264721A 用作atr激酶抑制剂的化合物 Compounds useful as kinase inhibitors atr
11/30/2011	CN102264720A 用于治疗癌症的异吲哚啉化合物 For the treatment of cancer isoindoline compound
11/30/2011	CN102264719A 结晶形式的有机化合物 Crystalline form of an organic compound
11/30/2011	CN102264701A 作为P2X<sub>7</sub>调节剂的二氢吡啶酮脲 As P2X <sub> Dihydropyridones urea 7 </ sub> modifier
11/30/2011	CN102260492A 喹诺酮衍生物作为oled发射材料在有机电致发光器件中的应用 Carbostyril derivative as oled emitting material in the organic electroluminescent device of Application
11/30/2011	CN102260245A 2,3-二氢喹唑啉酮类衍生物及其制备方法和应用 2,3-dihydro-quinazolinone derivatives and preparation method and application
11/30/2011	CN102260244A 一种稳定的雷贝拉唑钠化合物 A stable rabeprazole sodium compounds
11/30/2011	CN102260243A 沙奎那韦琥珀酸半酯盐及其制剂 Saquinavir acid half ester salts and preparations
11/30/2011	CN102260242A 甲磺酸伊马替尼多晶型物及其药用组合物 Imatinib mesylate polymorphs and pharmaceutical compositions
11/30/2011	CN102260241A 一种沙利度胺α晶型的工业化制备方法 One kind of thalidomide α crystalline form of industrial production method
11/30/2011	CN101528739B N-(2-羟基乙基)-n-甲基-4-(喹啉-8-基(1-(噻唑-4-基甲基)哌啶-4-亚基)甲基)苯甲酰胺及其制备方法和其用于治疗疼痛、焦虑症和抑郁症的用途 N- (2- hydroxyethyl) -n--methyl-4- (quinolin-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide its preparation method and its use for the treatment of pain, anxiety and depression
11/30/2011	CN101511787B 作为p2x7-受体拮抗剂的被取代的n-苯基甲基-5-氧代-脯氨酸-2-酰胺及它们的使用方法 Receptor antagonists as p2x7- n- substituted phenyl-5-oxo - proline-2-carboxamide, and their use
11/30/2011	CN101243139B 苯乙烯基硫化物染料 Styryl sulfide dye
11/30/2011	CN101076527B 三环酰苯胺螺乙内酰脲cgrp受体拮抗剂 Tricyclic acid anilide Lo Ethylurea cgrp receptor antagonist
11/29/2011	US8067615 Sulphonylpyrroles
11/29/2011	US8067613 Benzimidazole poly(ADP ribose)polymerase inhibitors
11/29/2011	US8067611 Substituted 1-(thiazolyl)-and 1-(isothiazolyl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
11/29/2011	US8067606 Gyrase inhibitors and uses thereof
11/29/2011	US8067602 Asymmetric cyanine fluorescent dyes, compositions and their use in staining biological samples
11/29/2011	US8067589 Heterocyclic compounds useful in treating diseases and conditions
11/29/2011	US8067588 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
11/29/2011	US8067443 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
11/29/2011	US8067442 Heterocyclic antiviral compounds
11/29/2011	US8067439 Biphenyl compounds useful as muscarinic receptor antagonists
11/29/2011	US8067428 Platelet ADP receptor inhibitors
11/29/2011	US8067407 Substituted dihydropyrazolones and their use
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2661334C Pyrimidone compounds as gsk-3 inhibitors
11/29/2011	CA2650248C Compounds and compositions as hedgehog pathway modulators
11/29/2011	CA2579291C Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2519733C Indazole having analgesic activity
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2479786C Quinoline derivatives and their use as 5-ht6 ligands
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/24/2011	WO2011146401A1 Novel inhibitors of hepatitis c virus replication
11/24/2011	WO2011146335A1 Piperidinyl-substituted lactams as gpr119 modulators
11/24/2011	WO2011145747A1 Prodrug of triazolone compound
11/24/2011	WO2011145548A1 Crystals of di(arylamino)aryl compound
11/24/2011	WO2011145340A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
11/24/2011	WO2011145022A1 2-phenyl benzoylamides
11/24/2011	WO2011144020A1 Indenoquinolone compound, preparation method and use thereof
11/24/2011	WO2011082267A3 Substituted triazolo-pyrazine compounds
11/24/2011	WO2011038097A3 Indolizine inhibitors of 5-lipoxygenase
11/24/2011	US20110288293 Isoquinoline derivative
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/2011	US20110288126 Substituted dioxopiperidinyl phthalimide derivatives
11/24/2011	US20110288120 Isoquinolinone derivatives as nk3 antagonists
11/24/2011	US20110288117 Substituted hydroxamic acids and uses thereof
11/24/2011	US20110288111 Inhibition of influenza m2 proton channel
11/24/2011	US20110288109 New compounds
11/24/2011	US20110288100 Therapeutic agents useful for treating pain
11/24/2011	US20110288094 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288090 Inhibitors of AKT Activity
11/24/2011	US20110288082 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288066 Phenoxy acetic acid derivatives
11/24/2011	US20110288065 Aminopyrazine derivative and medicine
11/24/2011	US20110288054 Compounds for the treatment of inflammatory disorders
11/24/2011	US20110287999 Optical brighteners and compositions comprising the same
11/24/2011	US20110287937 Ring-fused 2-pyridone derivatives and herbicides
11/24/2011	US20110284832 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
11/24/2011	CA2800143A1 Selective hdac inhibitors
11/24/2011	CA2799779A1 Piperidinyl-substituted lactams as gpr119 modulators
11/24/2011	CA2799708A1 2-phenyl benzoylamides
11/24/2011	CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/24/2011	CA2799390A1 Prodrug of triazolone compound
11/24/2011	CA2798735A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP2388258A1 Novel vanilloid receptor ligands and their use for producing medicaments
11/23/2011	EP2387562A1 Quinolinone derivatives useful for the treatment of cns disorders

1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 1080